EU-103

N/A

Report date: 2024/04/03 10:56:11

Base Information

Drug NameEU-103
Drug Alias NameEU-103
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAnti-V-set and immunoglobulin domain-containing protein 4
TargetsV-set and immunoglobulin domain-containing protein 4
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesEutilex
China Registration ClassN/A

Develop Information

Active CompaniesEutilex
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A